Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic
Study Details
Study Description
Brief Summary
During the COVID-19 pandemic, the time spent at the home of patients has increased because of national quarantine policies and patients' fear of getting sick. For this reason, in this ongoing process, patients have been unable to go to work regularly due to their chronic diseases (being on administrative leave) and their fear of going out. These reasons have prevented being physically active. The aim of the study is to evaluate the physical activity level, quality of life, glucose control, anxiety, depression, fear of hypoglycemia and loneliness perceptions of patients with type 1 diabetes mellitus during the COVID-19 pandemic period and compared with healthy controls.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Patients with type 1 diabetes mellitus Patients with Type 1 diabetes mellitus willing to participate in the study |
Other: Online Survey
Online surveys will be applied to all participants
|
| Healthy controls Healthy controls without chronic disease willing to participate in the study |
Other: Online Survey
Online surveys will be applied to all participants
|
Outcome Measures
Primary Outcome Measures
- Physical activity level [Five minutes]
Physical activity level using International Physical Activity Questionnaire - Short Form (IPAQ-SF) will be evaluated.
- General Quality of life [Ten minutes]
Quality of life using Short Form Health Survey (SF-36) will be evaluated.
Secondary Outcome Measures
- Depression [Three minutes]
Depression using Hospital Anxiety and Depression Scale will be evaluated.
- Anxiety [Three minutes]
Anxiety using Hospital Anxiety and Depression Scale will be evaluated.
- Self-reported hypoglycemia [Last seven day]
It will be questioned how many times patients have had hypoglycemic attacks (<4 mmol/L and common symptoms) in the last 7 days.
- Loneliness [Three minutes]
Loneliness using UCLA Loneliness Scale Short Form (ULS-8) will be evaluated.
- Hypoglisemia fear [Five minutes]
Hypoglisemia fear using Hypoglisemia Fear Survey (HFS) will be evaluated.
- Dyspnea [Two minutes]
Dyspnea during daily life activites using Modified Medical Research Dyspnea Scale will be evaluated.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Having been diagnosed with Type 1 Diabetes Mellitus
-
Willing to participate in the study
-
Participants whose native language is Turkish
Exclusion Criteria:
-
Unwilling to participate in the study
-
Having a cognitive disorder
-
Not being literate
-
Individuals who do not have sufficient knowledge and functional levels to fill out the online form
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Zeliha ÇELİK | Ankara | Çankaya | Turkey | 06490 |
Sponsors and Collaborators
- Gazi University
Investigators
- Study Chair: Zeliha ÇELİK, MSc, Gazi University
- Study Director: Meral BOŞNAK GÜÇLÜ, Prof, Gazi University
- Principal Investigator: Füsun BALOŞ TÖRÜNER, Prof, Gazi University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 91610558-604.01.02